Welcome
Support Centre
06 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A Trial Platform of Enhanced care for Depression in Primary Care
ISRCTN ISRCTN63222059
ClinicalTrials.gov identifier
Public title A Trial Platform of Enhanced care for Depression in Primary Care
Scientific title
Acronym N/A
Serial number at source G0300677
Study hypothesis 1. To design and refine a standardised ECD intervention protocol appropriate to the UK primary health care setting and acceptable to clinicians, practitioners and patients
2. To estimate contamination, clustering and effect size of the intervention within a pilot Phase II trial
3. To estimate trial recruitment rates through monitoring recruitment rates within the pilot Phase II trial
4. To examine the issue of treatment integrity and acceptability by monitoring the implementation of the ECD intervention protocol within a pilot Phase II trial and conducting qualitative stakeholder interviews
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Mental and Behavioural Disorders
Participants - inclusion criteria Depression presenting in Primary Care
Participants - exclusion criteria Depression not as primary diagnosis; suicidal intent
Anticipated start date 01/07/2004
Anticipated end date 30/03/2006
Status of trial Completed
Patient information material
Target number of participants 144
Interventions 1. Enhanced care for depression
2. Usual care
Primary outcome measure(s) Clinical response (change from baseline Hamilton depression HAM-D score), 50% reduction in depressive symptoms
Secondary outcome measure(s) 1. Quality of life (SF-12 & EQ-5D)
2. Health care utilisation (including GP visits, medication use, secondary care referrals)
3. Prescribing and adherence to medication measured against NICE guidelines (from individual patient records, filled prescriptions and patient self report)
Sources of funding Medical Research Council (UK)
Trial website
Publications Results: http://www.ncbi.nlm.nih.gov/pubmed/16814628
Contact name Prof  David  Richards
  Address Dept Health Sciences
Seebohm Rowntree Building
University of York
University Road
Heslington
  City/town York
  Zip/Postcode YO10 5DD
  Country United Kingdom
Sponsor University of York (UK)
  Address Prof Trevor Sheldon
Department of Health Sciences
Seebohhm Rowntree Building
University of York
University Road
Heslington
  City/town York
  Zip/Postcode YO10 5DD
  Country United Kingdom
  Sponsor website: http://www.york.ac.uk/
Date applied 17/05/2004
Last edited 15/04/2008
Date ISRCTN assigned 14/07/2004
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central